2,282
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Additional considerations for anti-tick vaccine research

ORCID Icon &
Pages 1019-1021 | Received 30 Nov 2021, Accepted 26 Apr 2022, Published online: 03 May 2022

Figures & data

Figure 1. Vaccinomics approaches for anti-tick vaccine development. new approaches have been proposed to improve vaccine efficacy, effectiveness, and safety. vaccinomics includes the characterization of tick-host-pathogen molecular interactions through integration of multiple omics technologies and big data analytics for the identification of candidate protective antigens. here, we propose quantum vaccinomics as a step forward through the identification and combination of immune protective epitopes (immunological quantum) for the development of more effective and safe vaccines. vaccinomics strategy for anti-tick vaccines considers other biomolecules such as glycan-based protein post-translational modifications (e.g. glycan alpha-gal), combination of tick and pathogen derived antigens and the use of different vaccine platforms such as nanoparticles, virus-like particles, and probiotic-based vaccines.

Figure 1. Vaccinomics approaches for anti-tick vaccine development. new approaches have been proposed to improve vaccine efficacy, effectiveness, and safety. vaccinomics includes the characterization of tick-host-pathogen molecular interactions through integration of multiple omics technologies and big data analytics for the identification of candidate protective antigens. here, we propose quantum vaccinomics as a step forward through the identification and combination of immune protective epitopes (immunological quantum) for the development of more effective and safe vaccines. vaccinomics strategy for anti-tick vaccines considers other biomolecules such as glycan-based protein post-translational modifications (e.g. glycan alpha-gal), combination of tick and pathogen derived antigens and the use of different vaccine platforms such as nanoparticles, virus-like particles, and probiotic-based vaccines.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.